BET inhibitor JQ1 could downregulate c-Myc in a time-dependent manner in MM cells, and the MM xenograft model treated by JQ1 also significantly decreased MM tumor burden and increased overall survival [9]. The gene discussed is MYC; the disease is Miyoshi myopathy.